Clinical Trial Update: Botulinum Toxin and/or Greater Occipital Nerve Block for Patients With Chronic Migraine [NA]

View source ↗

Summary

A clinical trial at Beni-Suef University is evaluating OnabotulinumtoxinA with or without a greater occipital nerve block for chronic migraine; the study is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: Beni-Suef University | Conditions: Chronic Migraine Headache, OnabotulinumtoxinA | NA | Status: NOT_YET_RECRUITING